GENTEC
0479.431.012 · rovalta.com · 22/09/2026
NORMAL SITUATION
GENTEC
Financial year 2021 · closed on 31/12/2021
Net result
24,8 k €
-91.2% YoY
Gross margin
25,5 k €
Equity
-10,1 k €
+72.8% YoY
Company — Normal situation.
Overview
What does GENTEC do?
GENTEC is a company registered in Belgium.
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0479.431.012
Legal form
Public limited company
Contributed capital
257 542,60 €
Latest accounts
31/12/2021
Joint committees (1)
- 218
Signals
ProfitablePositive cashflowPositive EBITDA
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 7 financial years
| 2021 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||
| Gross margin | 25,5 k € | – | – | – | – | – | – | ||||||
| EBITDA | 25,1 k € | +2102% | -1,3 k € | +70.4% | -4,2 k € | -575% | -627,6 € | +97.1% | -22 k € | +39.8% | -36,5 k € | -232% | -11 k € |
| Operating result | 25,1 k € | +2102% | -1,3 k € | +70.4% | -4,2 k € | -575% | -627,6 € | +98.4% | -39,1 k € | +39.0% | -64 k € | -17.2% | -54,6 k € |
| Net result | 24,8 k € | -91.2% | 280,8 k € | +1654% | -18,1 k € | -44.7% | -12,5 k € | +74.5% | -49 k € | +32.6% | -72,7 k € | -18.7% | -61,2 k € |
| Balance sheet | |||||||||||||
| Equity | -10,1 k € | +72.8% | -37,3 k € | +88.3% | -318,1 k € | -6.0% | -300 k € | -4.3% | -287,5 k € | -20.5% | -238,5 k € | -43.9% | -165,8 k € |
| Total assets | 1,8 k € | -92.1% | 22,1 k € | +19.1% | 18,6 k € | +9.9% | 16,9 k € | +89.4% | 8,9 k € | -65.7% | 26 k € | -64.6% | 73,6 k € |
| Cash | 1,4 k € | +187% | 500,1 € | +300% | 125,2 € | -77.4% | 554,2 € | -5.5% | 586,2 € | +34.1% | 437 € | +8.4% | 403 € |
| Debts | 11,9 k € | -80.0% | 59,4 k € | -82.4% | 336,6 k € | +6.3% | 316,8 k € | +6.9% | 296,4 k € | +12.1% | 264,5 k € | +10.5% | 239,4 k € |
Governance
Board of directors
Seen on filing of 31/12/2021 · 2 active · 9 ended
Active mandates
Adrian Philip LAWSON
ActiveARL Genetics Ltd NV
ActiveEnded mandates
Adrian Philip LAWSON
EndedARL Genetics Ltd NV
EndedAdrian Philip LAWSON
EndedARL Genetics Ltd NV
EndedFinancials
Annual accounts
Full financial information
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 | 01/01/2017 | 01/01/2016 |
| Closing of the financial year | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 | 31/12/2017 | 31/12/2016 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 26/04/2022 | 27/07/2021 | 10/07/2020 | 27/08/2019 | 31/08/2018 | 03/07/2017 |
| General meeting | 17/02/2022 | 15/05/2021 | 15/05/2020 | 15/05/2019 | 15/05/2018 | 15/05/2017 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
20 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2021 | 17/02/2022 | 26/04/2022 | Dutch | |
| Abridged model | 31/12/2020 | 15/05/2021 | 27/07/2021 | Dutch | |
| Abridged model | 31/12/2019 | 15/05/2020 | 10/07/2020 | Dutch | |
| Abridged model | 31/12/2018 | 15/05/2019 | 27/08/2019 | Dutch | |
| Abridged model | 31/12/2017 | 15/05/2018 | 31/08/2018 | Dutch | |
| Abridged model | 31/12/2016 | 15/05/2017 | 03/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 15/05/2016 | 16/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 15/05/2015 | 16/07/2015 | Dutch | |
| Full model | 31/12/2013 | 15/05/2014 | 04/06/2014 | Dutch | |
| Full model | 31/12/2012 | 15/05/2013 | 10/06/2013 | Dutch | |
| Full model | 31/12/2011 | 15/05/2012 | 06/06/2012 | Dutch | |
| Full model | 31/12/2010 | 16/05/2011 | 28/06/2011 | Dutch | |
| Full model | 31/12/2009 | 15/05/2010 | 23/08/2010 | Dutch | |
| Full model | 31/12/2008 | 15/05/2009 | 02/06/2009 | Dutch | |
| Full modelCorrection | 31/12/2007 | 15/05/2008 | 21/08/2008 | Dutch | |
| Full model | 31/12/2007 | 15/05/2008 | 31/07/2008 | Dutch | |
| Full model | 31/12/2006 | 11/07/2007 | 23/08/2007 | Dutch | |
| Full model | 31/12/2005 | 15/05/2006 | 09/11/2006 | Dutch | |
| Full model | 31/12/2004 | 17/05/2005 | 29/09/2005 | Dutch | |
| Full model | 31/12/2003 | 15/05/2004 | 10/06/2004 | Dutch |
Valuation
Estimate
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2021 · 2 active · 9 ended
Active mandates
Adrian Philip LAWSON
ActiveARL Genetics Ltd NV
ActiveEnded mandates
Adrian Philip LAWSON
EndedARL Genetics Ltd NV
EndedAdrian Philip LAWSON
EndedARL Genetics Ltd NV
EndedShareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2021Annual accounts 202124,8 k €↓
- 2013Annual accounts 2013280,8 k €↑
- 2012Annual accounts 2012-18,1 k €↓
- 2011Annual accounts 2011-12,5 k €↑
- 2010Annual accounts 2010-49 k €↑
- 2009Annual accounts 2009-72,7 k €↓
- 2008Annual accounts 2008-61,2 k €